Carcinoma of the male breast.

Current treatment options in oncology

Volumn 1, Issue 3, 2000, Pages 221-227

  De los Santos, J F ^a   Buchholz, T A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; HUMAN; MALE; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; REVIEW; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS, MALE; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HORMONES; HUMANS; MALE; MASTECTOMY, RADICAL; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 0034256307     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-000-0033-x     Document Type: Review

References (39)